Doctors address the pros and cons of Health Resources and Services Administration’s new guidance, including at-home ...
More than 99 percent of cervical cancers are caused by persistent high-risk HPV infection 1 Cervical cancer is nearly 100 percent preventable with proper HPV vaccination, screening and treatment; ...
The Food and Drug Administration approved the Roche cobas HPV Test to detect human papilloma virus through the use of cervical cells collected for a Pap test and stored in SurePath Preservative Fluid.
Basel, 16 June 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of a human papillomavirus (HPV) self sampling solution in countries accepting the CE mark. This new solution enables ...
Roche Diagnostics is looking to a new screening tool to help women learn in a more private way if they are at increased risk for cervical cancer—a self-collection test to identify HPV. With the test, ...
The U.S. Food and Drug Administration has approved the first DNA test that serves as a primary screening for the human papillomavirus in women ages 25 and older. The DNA test, cobas HPV Test ...
The FDA has approved an alternative to the traditional Pap smear. The U.S. Food and Drug Administration has approved a genetic test from Swiss drug maker Roche as the first U.S.-approved alternative ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved expanded indications for the self-collection of vaginal swabs for HPV tests. The approval will ...
However, more than 70% of the respondents indicated they would be interested in the option of collecting their own sample for screening if available. The research also demonstrated that with screening ...
Editor's Note: One hundred years ago, Dr. George Papanicolaou first put vaginal smears under the microscope to study human vaginal cytology, using samples supplied by his wife. [1] Dr. Papanicolaou ...
Survey findings from over 8,700 people in 12 countries show that half of those polled have inadequate understanding of HPV, with nearly one-third being unsure or unaware of it altogether.1 Findings ...